Market Overview

The Week Ahead In Cannabis: Canopy Earnings, CannaCon In Detroit And More

The Week Ahead In Cannabis: Canopy Earnings, CannaCon In Detroit And More

Last week was quite eventful for the cannabis industry, with Colorado reaching $1.0 billion in sales and Kroger Co (NYSE: KR) announcing plans to start carrying CBD products.

Here’s what you should keep an eye on this week and some of the most important events to consider.

Need more cannabis news? Check out all of our coverage here.

Busy Week For Canopy Growth

Canopy Growth Corp (NYSE: CGC) will have two important events in the second half of the week. On Wednesday, shareholders of Canopy Growth and Acreage Holdings Inc (OTC: ACRGF) will hold a meeting to vote on their merger.

On Thursday, Canopy Growth is expected to report its financial results for the fourth quarter of 2019.

Other News

On Monday, MediPharm Labs Corp. (OTC: MEDIF) closes its stock offering of 10.82 million shares for total gross proceeds of around $60 million to a group of underwriters, including GMP Securities and BMO Capital Markets.

On Tuesday, the Anchorage Assembly will hold its regular meeting to discuss on-site consumption of edibles at licensed retail stores. Alaska in April became the first state to legalize on-site consumption of cannabis.

On Friday, Curaleaf Holdings Inc (OTC: CURLF) will open the first medical cannabis dispensary in Brevard County, Florida.


NCIA Cannabis Caucus Oakland - June 18

NCIA Cannabis Caucus San Diego - June 20

CannaCon Detroit – June 21-22

Related Links:

mood33 Announces Distribution Agreement With Carol Bartz And Joe Montana-Backed Caliva

How One Cannabis Company Drastically Reduced Plastic Waste By Childproofing Its Vapes

Posted-In: Cannabis Earnings News Offerings Previews Events Markets Trading Ideas Best of Benzinga


Related Articles (CGC + ACRGF)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Huawei Acknowledges Potential $30B Revenue Shortfall

Aclaris Announces Positive Results From Alopecia Treatment Trial